In this study, a case of post-COVID telogen effluvium was reported in which fever and stress following COVID-19 triggered temporary hair loss, and topical treatment showed positive results in improving this condition.
18 citations
,
February 2014 in “PubMed” This article reviews current diagnostic and treatment approaches for androgenetic alopecia but reports no new results, focusing on its progression and medical management options.
2 citations
,
May 2018 in “Journal of The American Academy of Dermatology” This study examined 15 female patients with hypothyroidism to investigate the characterization of their alopecia and ruled out other causes, using medical histories, and clinical, trichoscopic, and histologic findings.
3 citations
,
April 2002 in “The Lancet” In this case report, the authors identified giant cell arteritis as the underlying cause of bitemporal hair loss and scalp tenderness in a 70-year-old woman, initially misdiagnosed as age-related symptoms.
December 2024 in “Asian Journal of Medical Sciences” This study observed that a majority of female patients with chronic telogen effluvium had low serum ferritin levels without signs of clinical anemia, suggesting a possible link between low iron stores and hair loss.